kresmion.
Pull a receipt

CollPlant Biotechnologies Ltd (CLGN)

Sector
Healthcare
Industry
Biotechnology
Last price
$3.97
As of

Kresmion compiles this page from CLGN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

CollPlant Biotechnologies Ltd (CLGN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-05.

As of . Source: SEC EDGAR filings for CLGN. Method and limitations.

COMPANY DOSSIER

See the full CLGN dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for CLGN on one page. Preview it with sample data, then open it live with a free account.

Preview the CLGN dossier

Active events for CLGN

  • lowEarnings below estimates

    Q1-2025: EPS $-0.13 vs $-0.0408 estimate, -0.09 on a near-zero consensus

    All 2026-05-30 events →
  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 96.1% - EPS $-0.28 vs $-0.1428 estimate

    All 2026-05-30 events →
  • mediumEarnings below estimates

    Q3-2025: Missed consensus by 270.8% - EPS $-0.27 vs $0.1581 estimate

    All 2026-05-30 events →
  • mediumEarnings below estimates

    Q4-2025: Missed consensus by 34.2% - EPS $-0.26 vs $-0.1938 estimate

    All 2026-05-30 events →

FREE, NO ACCOUNT

Every event on CLGN, as it fires

New filings, 13F moves and cross asset events on CLGN land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, CLGN

Going concern statement

CLGN's 20-F filed Mar 26, 2026 states:

Based on the Company's cash position as of March 15, 2026, alongside projected continued negative cash flows from operating activities, substantial doubt exists regarding our ability to remain as a going concern.

Read the 20-F on SEC EDGAR Every company with a going concern statement

More data on CLGN

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in CLGN on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CLGN in the last 180 days.

Upstream: SEC EDGAR filings for CLGN

Kresmion, "CollPlant Biotechnologies Ltd (CLGN) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/CLGN. Upstream data: SEC EDGAR filings for CLGN.

Link to this data (HTML):

<a href="https://kresmion.com/research/CLGN">CollPlant Biotechnologies Ltd (CLGN) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow CLGN on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CLGN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the CLGN dossier
Share

The CLGN intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.